Letter

Neuraminidase inhibitors for influenza A and B

BMJ 2003; 327 doi: 10.1136/bmj.327.7406.105-c (Published 10 July 2003)
Cite this as: BMJ 2003;327:105.4

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Antivirals need to be protected from adverse conditions to retain effectiveness

  1. Subhash C Arya, clinical microbiologist (subhashji@hotmail.com),
  2. Nirmala Agarwal, chief, obstetrics and gynaecology
  1. Sant Parmanand Hospital, 18 Alipore Road, Delhi 110054, India

    EDITOR–Cooper et al outlined the role of neurominadase inhibitors in prophylaxis against and treatment of influenza.1 These agents would be important during the early phase of any outbreak of influenza. Nevertheless, their efficacy would be reduced if …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular